Vivactil or Surmontil, both tricyclic antidepressants popularly prescribed for anxiety disorders, exhibit distinct pharmacological characteristics. Vivactil (nortriptyline), known for its potent suppressing effects on serotonin and norepinephrine reuptake, reveals a higher affinity for alpha-2 adrenergic receptors. This influences its potential for